KALA BIO, Inc.
through Mar 17, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 13, 2026 · D | Mar 17, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $4,200,000 | $1,753,500 | $-2,446,500 |
| Reported amount sold | $2,250,600 | $1,753,500 | $-497,100 |
| Reported investor count | — | — | — |
| Reported minimum investment | $44,905 | $1,753,500 | $1,708,595 |
Earlier SEC source: 0001829126-26-001292 · Later SEC source: 0001829126-26-002408
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $1,753,500
- Reported amount sold
- $1,753,500
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001829126-26-002408D · Mar 17, 2026 · PharmaceuticalsOffering: $1,753,500Sold: $1,753,500
-
0001829126-26-001292D · Feb 13, 2026 · BiotechnologyOffering: $4,200,000Sold: $2,250,600